Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
167.00    2.00 (1.21%)
Bid:
165.50
Ask:
168.50
Spread: 3.00 (1.813%)
Market Cap: £32.61m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Share Buyback Programme

17 Apr 2026 07:00

RNS Number : 8371A
Palace Capital PLC
17 April 2026
 

LEI:2138009JDFQOXJFCJQ05

17 April 2026

Palace Capital PLC

 ("Palace Capital" or the "Company") 

Share Buyback Programme

The Board of Directors (the "Board") of Palace Capital announces it has approved a share buyback programme of up to 400,000 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") (the "Buyback Programme") as the initial step of a wider capital return programme it is progressing with its advisers.

The Company has instructed Cavendish to conduct the Buyback Programme on its behalf on a broker-managed basis, with trading decisions taken independently of the Company based parameters set by the Board. The Buyback Programme commences today and will end no later than six months from today, on 17 October 2026, or earlier if the maximum number of Ordinary Shares has been reached or the Company's buyback authority is not renewed at or before its next annual general meeting.

The Buyback Programme will be conducted in accordance with the terms of the Company's authority to make market purchases of its own Ordinary Shares granted to it by shareholders on 9 July 2025 (the "Authority"), including that the price paid per Ordinary Share will not be less than the nominal value of the Ordinary Shares, and the maximum price paid per Ordinary Share (excluding expenses) will be no more than the higher of either 105 per cent. of the average middle market closing price of an Ordinary Share as shown on the Daily Official List for the five business days preceding the date of any buyback; and an amount equal to the higher of the price of the last independent trade of an Ordinary Share and the highest current independent bid for an Ordinary Share on the trading venue where the purchase is carried out.

The Authority will expire on 9 October 2025 or, if earlier, at the conclusion of the Company's next annual general meeting ("AGM"), at which a proposal (amongst others) will be put to shareholders to renew the Company's ability to make market purchases of its Ordinary Shares. Accordingly, the Buyback Programme will continue after that date pursuant to such renewed authority and will be conditional on the approval of the same by shareholders. The Company intends to hold all Ordinary Shares so purchased in treasury during the course of the Buyback Programme and, following completion of the Buyback Programme, will seek to cancel the Ordinary Shares.

Due to the limited liquidity in the issued Ordinary Shares, a buyback of Ordinary Shares pursuant to the Authority (or its successor) on any given trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on the London Stock Exchange and could exceed 25 per cent. of the average daily trading volume and, accordingly, the Company will not benefit from the exemption contained in Article 5(1) of Regulation (EU) No. 596/2014 as adopted into UK law by the European Union (Withdrawal) Act 2018.

The Company will make further announcements in due course following any share purchases under the Buyback Programme.

 

Enquiries:

 

Palace Capital plcChristian Kappelhoff-Wulff, Non-Executive Chairmanckw@palacecapitalplc.com

Financial PR

FTI ConsultingDido Laurimore / Andrew Davis

Tel: +44 (0)20 3727 1000

palacecapital@fticonsulting.com

 

Broker

Cavendish

Matt Lewis, Head of Corporate BrokingTel: +44 (0)20 7397 1920mlewis@cavendish.com

 

This announcement contains inside information for the purposes of Article 7 of the UK version of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUNVBRNRUSAAR
Date   Source Headline
2nd Aug 20247:00 amRNSDirector/PDMR Shareholding
24th Jul 202411:03 amRNSResult of AGM
24th Jul 202410:53 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSDISPOSALS AND CASH UPDATE
22nd Jul 20248:55 amRNSHolding(s) in Company
18th Jul 20247:00 amRNSDirector/PDMR Shareholding
17th Jul 20242:30 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSTransaction in Own Shares
11th Jul 20247:00 amRNSResult of Tender Offer
9th Jul 202410:45 amRNSResult of General Meeting
19th Jun 20247:00 amRNSAnnual Report and Notice of Annual General Meeting
13th Jun 20247:00 amRNSTender Offer
6th Jun 20247:00 amRNSPreliminary Results for year ended 31 March 2024
4th Jun 20247:00 amRNSNotice of Results
29th Apr 20241:15 pmRNSBoulton House disposal
18th Apr 20247:00 amRNSDISPOSALS AND DEBT UPDATE
28th Mar 202412:45 pmRNSTotal Voting Rights
12th Mar 20247:00 amRNSDividend Declaration
8th Feb 20243:49 pmRNSHolding(s) in Company - Amendment
8th Feb 20243:30 pmRNSHolding(s) in Company
8th Feb 20243:29 pmRNSHolding(s) in Company
7th Feb 20247:00 amRNSDISPOSALS AND DEBT UPDATE
4th Dec 20234:00 pmRNSResult of General Meeting
15th Nov 20233:15 pmRNSHolding(s) in Company
15th Nov 20237:02 amRNSNotice of General Meeting
15th Nov 20237:01 amRNSDirectorate Change
15th Nov 20237:00 amRNSInterim Results
17th Oct 20234:00 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSDividend Declaration
6th Sep 20237:00 amRNSTransaction in Own Shares
4th Sep 20231:40 pmRNSDirector Declaration
29th Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20237:00 amRNSDirector Dealing
15th Aug 202310:07 amRNSNotification of Major Holdings
15th Aug 20239:56 amRNSNotification of Major Holdings
14th Aug 20237:00 amRNSTransaction in Own Shares
10th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSShare Buyback and Total Voting Rights
2nd Aug 20237:00 amRNSSale of Maidenhead office property for £9.6m
26th Jul 20232:15 pmRNSResult of AGM
26th Jul 20237:00 amRNSAGM Trading Update
19th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20237:00 amRNSShare Buyback and Total Voting Rights
30th Jun 20237:00 amRNSTransaction in Own Shares
28th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSAnnual Report and Notice of Annual General Meeting
23rd Jun 20237:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.